Aligos Therapeutics (ALGS) Long-Term Deferred Tax (2022 - 2024)
Aligos Therapeutics' Long-Term Deferred Tax came in at $1.76 million for Q4 2024, down 99.9% from $2.38 billion a year earlier.
Analysis
Aligos Therapeutics (ALGS) Long-Term Deferred Tax (2022 - 2024) Analysis & Trends
- Going back by year, Long-Term Deferred Tax was $2.38 billion in FY2023 (-25.0%) and $3.17 billion in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 2.38 Bn |
| Dec 31, 2022 | 3.17 Bn |
API Access
Aligos Therapeutics Long-Term Deferred Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-deferred-tax", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();